Finley says her physician told her a prior authorization was on file, but when she tried to refill her prescription, the pharmacist told her that Zepbound was denied
"It can affect whether they seek care, whether they talk openly with providers and how they manage their health overall." Though GLP-1s have often been described as a boon to managing obesity rate in the U.S., the idea that they are an "easy way out" persists, said Standen and fellow study authors Sean Phelan, professor of health services research at the Mayo Clinic, and Janet Tomiyama, professor of psychology at the University of California, Los Angeles
By influencing these pathways, semaglutide may affect feelings of satiety and appetite control in some individuals
Yet as these data show, Southern residents are less likely than others to have access to GLP-1 drugs in state regulated health insurance markets, providing another example of how state of residence can affect access to healthcare in critical ways.
They are proven to help promote fullness and even potentially help with weight loss
Ready to Start Your Peptide Protocol